Abstract:Baculovirus has been widely used for the production of recombinant proteins in insect cells. The extremely high yield by baculovirus-infected insect cells or larvae makes it an attractive tool for pharmaceutical protein production. Since the finding that baculovirus can efficiently transduce mammalian cells, the applications of baculovirus have been greatly expanded. Although AcMNPV (Autographa californica multiple NPV) fails to replicate in vertebrate cells, it does express alien genes with levels of expression that are dependent on the strength of the promoter used to drive transcription of the foreign gene. Following these findings, subsequent studies have rapidly expanded the list of permissive cells that include cell lines originating from human, rodent, porcine, bovine and even fish sources. Many tries have been done to study the mechanism of baxulovirus entry into mammalian cells, but the events responsible for virus uptake and detailed mechanisms of intracellular movement and nuclear entry of the virus are still largely unknown. The application of modified baculoviruses for in vivo gene delivery has also been demonstrated. In contrast to other commonly used viral vectors, baculoviruses have the unique property of being incapable of initiating a replication cycle and producing infectious virus in mammalian cells. The AcMNPV genome is large, thus rendering the virus flexibility to carry multiple genes or large inserts. The recombinant viruses can be readily constructed and produced to high titers simply by infecting insect cells, initiate little to none microscopically observable cytopathic effects on mammalian cells and have a good biosafety profile. These attributes will undoubtedly lead to the increased application and continued development of this system for efficient gene delivery into mammalian cells.

Recombinant Protein Production in Suspension Mammalian Cells Using the BacMam Baculovirus Expression System

Comprehensive Comparison of Baculoviral and Plasmid Gene Delivery in Mammalian Cells

A novel application of baculovirus in mammalian gene therapy]

Bacterial artificial chromosomes improve recombinant protein production in mammalian cells

Rapid Titration of Recombinant Baculoviruses Based on NanoLuc Secretion in Early Infection.

A Novel Method for Isolation of Membrane Proteins: A Baculovirus Surface Display System

Multi-Gene Recombinant Baculovirus Expression Systems: From Inception to Contemporary Applications

Mammalian cell culture for production of recombinant proteins: A review of the critical steps in their biomanufacturing

A Versatile Method for Inducible Protein Production in 293 Cells Using the PiggyBac Transposon System

Heterologous protein production using euchromatin-containing expression vectors in mammalian cells

Robust and resource-efficient production process suitable for large-scale production of baculovirus through high cell density seed train and optimized infection strategy

EPISOMAL VECTORS FOR STABLE PRODUCTION OF RECOMBINANT PROTEINS AND ENGINEERED ANTIBODIES

Production of Recombinant Viral Antigens Using the Baculovirus-Insect Cell Expression System

Serum‐free medium for recombinant protein expression in insect cells

Advanced Establishment of Stable Recombinant Human Suspension Cell Lines Using Genotype-Phenotype Coupling Transposon Vectors

Mamestra brassicae NIAS-Mb-32 cell strain 2g2 enables high-yield recombinant protein production in baculovirus-free and baculovirus-based insect cell expression

Genetic engineering of baculovirus-insect cell system to improve protein production

Development of a rapid and efficient BmNPV baculovirus expression system for application in mulberry silkworm, Bombyx mori

Application and research progress of MultiBac: A review

Transient Recombinant Protein Expression in Mammalian Cells

HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors